Mainz Biomed

Biotechnology

Founded in 1/1/21

Mainz, Rheinland-Pfalz, Germany

http://www.mainzbiomed.com

For Profit

About Mainz Biomed

Mainz BioMed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. Mainz Bio is Specializing in the early detection of cancer with it's flagship product COloAlert.

Company Metrics

Employees: 11-50
Monthly Visits: 235
Tech Stack: 9 active products

Financial Information

Estimated Revenue: Less than $1M
Total Funding: 22500000 USD
Last Funding: 22500000 USD (Post-IPO Equity)
Funding Status: IPO

Technology Stack

Mainz Biomed actively uses 9 products in their tech stack.

Market Presence

Industries: Biotechnology

Headquarters: Mainz, Rheinland-Pfalz, Germany

Employees